Clinical Image
A case of a rare primary tumor of the mediastinum presenting with superior vena cava syndrome
1 MBChB, Department of Cardiothoracic Surgery, Dunedin Hospital, Dunedin City, New Zealand
2 BSN, Intensive Care Unit, Dunedin Hospital, Dunedin City, New Zealand
3 MBChB, Southern Community Labs, Dunedin City, New Zealand
Address correspondence to:
Ramanen Sugunesegran
201, Great King Street, Dunedin Public Hospital, Dunedin City,
New Zealand
Access full text article on other devices
Access PDF of article on other devices
Article ID: 100112Z10RS2022
doi: 10.5348/100112Z10RS2022CI
How to cite this article
Sugunesegran R, Kumate C, Ross C. A case of a rare primary tumor of the mediastinum presenting with superior vena cava syndrome. J Case Rep Images Oncology 2022;8(2):28–30.ABSTRACT
No Abstract
Case Report
A 44-year-old active man presented with a two-month history of shortness of breath on exertion with an insidious onset. This was associated with swelling of his face and eyes that was worse in the mornings. There were no other symptoms. All his vital signs were normal.
Chest X-ray demonstrated a large soft tissue density in the mediastinum extending into the right upper zone, measuring 10.7 cm across, resulting in tracheal displacement. This was confirmed on CT imaging (Figure 1) which showed a mixed density mass filling the mediastinum and extending into both pleural cavities. The superior vena cava and innominate vein was laterally displaced alongside right tracheal deviation and bilateral compression of upper lung lobes. Percutaneous biopsy suggested a benign soft tissue tumour with features suggestive of a lipoma variant and no evidence of malignancy.
After multidisciplinary discussion, initial surgical therapy was performed. Resection via median sternotomy was performed. The excised tumor (Figure 2) was large in nature and was completely excised including tumor extensions into the neck. Full mediastinal clearance was performed due to the indurated and inflamed appearance of the mediastinal fat. Histology demonstrated well-differentiated liposarcoma with areas of low grade fibrosarcoma-like dedifferentiation (Figure 3 and Figure 4). Recovery was uneventful and the patient underwent adjuvant radiotherapy, remaining symptom free at immediate follow-up.
Unfortunately the patient returned two years later and CT scan showed recurrence involving the supraclavicular and retroclavicular area with right paratracheal extension. The tumour was re-excised but was found to be adherent to the thyroid with infiltration into one of the lobes. The patient underwent post-operative radiotherapy. Unfortunately two years later further recurrence of the liposarcoma was found. After multidisciplinary discussion the patient was deemed not for further surgery, and had palliative chemotherapy before succumbing to the disease process.




Discussion
Mediastinal tumours after frequently symptomless until they reach a size resulting in mass effects [1]. Superior vena cava (SVC) obstruction is generally a late sign as the tumor will have taken up a large portion of the mediastinum. Superior vena cava syndrome is highly suggestive of thoracic malignancy and is generally associated with poor prognosis [2]. Management of SVC syndrome is determined largely by the underlying pathology and can include chemo/radiotherapy as well as stenting or surgical bypass in selected cases [2]. In the above case a mediastinal liposarcoma resulted in SVC syndrome and after surgical resection, the symptoms rapidly subsided.
Liposarcomas, malignant tumors arising from adipose tissue are rare in comparison to other adipose tissue derived tumors and have a range of malignant potential [1]. Four histological entities are described: myxoid, round-cell, well-differentiated, and pleomorphic [1]. Treatment for all types include surgical resection followed by adjuvant radiotherapy. The role of chemotherapy in these mediastinal tumors is still uncertain [1]. Poor prognostic factors for liposarcomas irrespective of histological subtype are increasing tumor size (especially >10 cm), higher tumor grade (Grades II and III), involved surgical resection margin and if clinical presentation was in the recurrent stage of the disease [3]. However, differences in outcome according to histologic variance is harder to quantify as outcomes can be dependent on tumor location and administration of radiotherapy which is likely a reflection on the ability to achieve adequate surgical margins. What is known from large case series is that myxoid liposarcomas are likely to be classified as grade I and 10-year incidence of distant metastasis was only 5% which confers a more favorable prognosis [3]. The presence of >5% round cells on histology can result in a >1.5 risk of dying from the disease but has a similar distant-metastasis rates to that of the pleomorphic and well-differentiated liposarcoma variant [3]. Well-differentiated liposarcomas as in the above case typically have a high mortality with a five-year survival rate of 65% [3]. Recurrence is possible; our case is highlighting the importance of follow-up despite multiple surgical resections.
Conclusion
Primary mediastinal liposarcomas are extremely rare mesenchymal tumors that have high potential of recurrence even after surgical excision. This case describes a classic presentation of a rare mediastinal liposarcomas which account for approximately 1% of mediastinal tumors. These tumors often present slowly with symptoms due to mass effect. Superior vena cava syndrome should prompt expedited investigation for the patient’s presentation as it is often associated with malignancy and often in the later stages of the disease. There is limited research, and more studies should be directed toward the best management course of this disease.
REFERENCES
1.
Macchiarini P, Ostertag H. Uncommon primary mediastinal tumours. Lancet Oncol 2004;5(2):107–18. [CrossRef]
[Pubmed]
2.
Lepper PM, Ott SR, Hoppe H, et al. Superior vena cava syndrome in thoracic malignancies. Respir Care 2011;56(5):653–6. [CrossRef]
[Pubmed]
3.
Fiore M, Grosso F, Lo Vullo S, et al. Myxoid/round cell and pleomorphic liposarcomas: Prognostic factors and survival in a series of patients treated at a single institution. Cancer 2007;109(12):2522–31. [CrossRef]
[Pubmed]
SUPPORTING INFORMATION
Author Contributions
Ramanen Sugunesegran - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Christina Kumate - Substantial contributions to conception and design, Analysis of data, Interpretation of data, Drafting the article, Final approval of the version to be published
Cody Ross - Acquisition of data, Analysis of data, Interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published
Data Availability StatementThe corresponding author is the guarantor of submission.
Consent For PublicationWritten informed consent was obtained from the patient for publication of this article.
Data AvailabilityAll relevant data are within the paper and its Supporting Information files.
Competing InterestsAuthors declare no conflict of interest.
Copyright© 2022 Ramanen Sugunesegran et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.